June 28, 2025 - 22:37

A new biometric technology has been introduced at the Cross Border Xpress (CBX) to significantly reduce wait times for U.S. citizens returning to the United States. This cutting-edge system aims to enhance the travel experience by expediting the entry process, allowing travelers to move through security and immigration checks more swiftly.
The implementation of this technology comes in response to growing concerns about long wait times at border crossings, particularly during peak travel seasons. By utilizing advanced biometric scanning methods, the CBX hopes to streamline the identification process, ensuring that travelers can quickly and efficiently verify their identities.
Officials at the airport terminal expressed optimism about the potential impact of this technology, noting that it could not only improve passenger flow but also enhance overall security measures. As travel demand continues to rise, the adoption of such innovative solutions is crucial for maintaining a seamless experience for travelers crossing the border.
April 10, 2026 - 03:59
Verneek's Deep Technology Tackles Retail IssuesThe retail sector is turning to sophisticated artificial intelligence to solve persistent operational challenges, with companies like Verneek at the forefront. According to its CEO, Dr. Nasrin...
April 9, 2026 - 12:09
California lawmaker introduces bill to help prevent, de-escalate police chases with new technologyIn a direct response to the dangers of high-speed police pursuits, a California lawmaker has introduced new legislation focused on de-escalation and prevention. The bill arrives amid heightened...
April 8, 2026 - 20:04
Omatic Releases Fourth Annual Nonprofit Technology Ecosystem Trends Report, Uncovers a Sector Drowning in Data—And the Struggle to Trust ItA comprehensive new survey of over 800 nonprofit professionals has uncovered a sector at a critical technological crossroads, grappling with an overwhelming influx of data while simultaneously...
April 8, 2026 - 08:38
Halozyme and Vertex sign deal for Hypercon technologyIn a significant move within the biopharmaceutical industry, Halozyme Therapeutics has entered into an exclusive worldwide partnership and licensing agreement with Vertex Pharmaceuticals. The multi...